Cellular Technology Limited CTL Revenue and Competitors
Estimated Revenue & Valuation
- Cellular Technology Limited CTL's estimated annual revenue is currently $24.3M per year.
- Cellular Technology Limited CTL's estimated revenue per employee is $155,000
Employee Data
- Cellular Technology Limited CTL has 157 Employees.
- Cellular Technology Limited CTL grew their employee count by 8% last year.
Cellular Technology Limited CTL's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller | Reveal Email/Phone |
2 | General Counsel | Reveal Email/Phone |
3 | Director Information Systems | Reveal Email/Phone |
4 | Director Laboratory, GLP | Reveal Email/Phone |
5 | Director CRO laboratory CTL | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Director T cell Immune Monitoring - Research and Development | Reveal Email/Phone |
8 | Director Basic B cell Research | Reveal Email/Phone |
9 | Legal Counsel /GDPR Data Protection Officer and HIPAA Privacy Officer | Reveal Email/Phone |
10 | Director Human Resources | Reveal Email/Phone |
Cellular Technology Limited CTL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $119.4M | 659 | N/A | N/A | N/A |
#2 | $168.6M | 860 | N/A | N/A | N/A |
#3 | $142.9M | 704 | N/A | N/A | N/A |
#4 | $950.2M | 2366 | -25% | $511.5M | N/A |
#5 | $1.5M | 17 | N/A | N/A | N/A |
#6 | $5M | 32 | N/A | N/A | N/A |
#7 | $157.9M | 778 | 31% | N/A | N/A |
#8 | $281.5M | 1135 | -7% | $411.9M | $6.1B |
#9 | $4.2M | 36 | N/A | N/A | N/A |
#10 | $229.8M | 681 | N/A | N/A | N/A |
#11 | $12.6M | 52 | N/A | N/A | N/A |
#12 | $0.4M | 6 | N/A | N/A | N/A |
#13 | $2.2M | 22 | N/A | N/A | N/A |
#14 | $7.6M | 49 | N/A | N/A | N/A |
#15 | $2M | 20 | N/A | N/A | N/A |
#16 | $5M | 43 | 0% | N/A | N/A |
#17 | $13.6M | 54 | N/A | N/A | N/A |
#18 | $5.5M | 47 | N/A | N/A | N/A |
#19 | $640.7M | 1868 | N/A | N/A | N/A |
#20 | $2.7M | 27 | N/A | N/A | N/A |
What Is Cellular Technology Limited CTL?
Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL's mission has been Elevating ELISPOT to an Exact Science. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monitoring. We offer: Contract Laboratory: Immune monitoring with an emphasis on T and B cells in a CLIA-certified, GLP-compliant laboratory with processing capabilities of up to 450 samples per week. Assays include: ELISPOT, ELISA, FACS, CBA, Proliferation, and more. Comprehensive solutions for sample processing: Whole blood processing with optimized PBMC cryopreservation methods that ensure good cell functionality. All-around ELISPOT including: Protocols and reagents for human PBMC cryopreservation, processing, and testing Human PBMC reference samples as reference standards for assay performance. Extensive Cryopreserved PBMC Library: The largest commercially available library of donors available both uncharacterized and with established T cell reactivity. ImmunoSpot® Kits: Standardized T Cell and B Cell ELISPOT Kits. Single- and Double-color Enzymatic ELISPOT. Up to Four-color T Cell & B Cell FluoroSpot Kits. Cytokine/Antibody combination multicolor FluoroSpot Kits. Non-radioactive human Natural Killer/ADCC Assessment Kits Positive and negative control antigens. Consultation and Hands-on Workshop Training on the use of ELISPOT for immune monitoring. ImmunoSpot® Analyzers for automated and objective ELISPOT data analysis and streamlined data processing with audit trails. BioSpot® Analyzers for serum antibody neutralization tests; Viral Plaque, PRNT, Viral ICA, Serum Neutralization Assays, and Serum Bactericidal Assays, all with multicolor capability. Serum-free Media for washing, testing, and freezing PBMC Plate Scanning and Analysis Services
keywords:Biotechnology,Healthcare,Medical DiagnosticsN/A
Total Funding
157
Number of Employees
$24.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cellular Technology Limited CTL News
Immunotherapy is one of the more appealing and effective kinds of cancer treatment when it works, but the relatively new approach is still fairly limited in...
The researchers did caution that their work is limited by a small sample ... produce pretty dramatic increases in sensitivity to CTL attach.
Funding: Supported by Guangzhou Science and Technology Innovation Committee ... although limited mutations were found within dominant CTL...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.3M | 196 | N/A | N/A |
#2 | $24.9M | 226 | N/A | N/A |
#3 | $51.7M | 229 | 21% | N/A |
#4 | $47.4M | 246 | 7% | N/A |
#5 | $66.8M | 248 | 7% | N/A |